Euclidean Fund For Cancer Research is a Hedge Fund in Washington, that has raised $13.42 mm from 8 investors, for an equity fund started in May 2018. Data from SEC filing on 4 Oct 2022.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
SEC advisor number
801-72806
FINRA CRD number
159018
AUM ?
$16.77 mm
Address
Euclidean Fund For Cancer Research
EUCLIDEAN TECHNOLOGIES GP, LLC
800 5TH AVENUE, SUITE 4100
SEATTLE
WA 98104
EUCLIDEAN TECHNOLOGIES GP, LLC
800 5TH AVENUE, SUITE 4100
SEATTLE
WA 98104
Phone
206-839-8586
Brochures
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Euclidean Technologies Management, LLC | $124.85 mm | |
Euclidean Fund I, L.P. | $108.08 mm | Hedge Fund |
the Euclidean Fund for Cancer Research LP | $16.77 mm | Hedge Fund |
Latest filings (excl ownership)
D/A
Indefinite amount in investment fund / equity, sold $13.42M, 8 investors
4 Oct 22
D/A
Indefinite amount in investment fund / equity, sold $13.42M, 8 investors
7 Oct 21
D/A
Indefinite amount in investment fund / equity, sold $10.42M, 8 investors
7 Oct 20
D/A
Indefinite amount in investment fund / equity, sold $10.42M, 8 investors
7 Oct 19
D/A
Indefinite amount in investment fund / equity, sold $10.42M, 8 investors
1 May 19
D
Indefinite amount in investment fund / equity, sold $3.75M, 8 investors
1 May 18
Latest ownership filings
No filings